Gross Margin

Investors eye Kontoor Brands' March 3rd report, seeking proof of sustained momentum for Wrangler and Helly Hansen amid a tough consumer market.

Following a landmark FDA approval, IceCure Medical's long-serving CFO is exiting, placing the company at a pivotal financial crossroads for its new treatment.

With its IPO complete, Cambridge Acquisition Corp. enters a disciplined SPAC market with a clear focus on wellness, hemp, and psychedelic tech targets.

As Nordstrom marks 125 years, its year-long celebration is more than a party—it's a strategic move to bolster loyalty and adapt in a tough market.

As Omada Health preps its 2025 results, all eyes are on whether its blend of tech, human coaching, and GLP-1 support can deliver sustainable profits.

Bionano's 2026 virtual event will showcase how Optical Genome Mapping is revolutionizing cancer and genetic disease research and paving a path to clinical use.

As it marks its 40th year, the legal finance giant's impressive 3.0x return on capital highlights the growing appeal of legal assets as a stable asset class.

The private jet operator posted record revenue with fewer planes, achieving its first-ever quarter of positive Adjusted EBITDA in a major turnaround.

Semiconductor leader Astera Labs launches a new R&D hub in Israel, hiring top tech veterans to develop next-gen connectivity for the demanding AI era.

Backed by robust earnings and strategic acquisitions, Atmus Filtration's latest dividend signals strong financial health and a commitment to shareholder returns.

Tandy Leather clarifies a key date for its large $0.75 special dividend. Learn what the unusual timing means for investors and what it signals about the company.

Strong investor demand boosts financing for BC's Golden Triangle exploration, highlighting Canada's strategic push into the critical minerals sector.

As DICK'S Sporting Goods preps its Q4 report, all eyes are on the costly Foot Locker integration and whether its core business can offset the drag.

Karat Packaging rewards investors with a $0.45 quarterly dividend, but can the high-yield payout be sustained amid rising costs and shrinking margins?

Mawson Infrastructure reports a steep Q4 revenue drop but a smaller annual loss, clearing major legal hurdles to focus on its AI and green energy future.

Facing a stock slump and operational woes, Clorox leaders must deliver a convincing turnaround plan at the upcoming CAGNY investor conference.

Sun Life and DentaQuest open nominations for their Health Access Hero Awards, offering grants to groups fighting critical health disparities.

A health-tech firm with a mission for free care and a $1.3B valuation eyes a Nasdaq listing, but its revenue-free history raises critical questions.

New 2025 data shows contractors using platforms like ServiceTrade cut emergency calls 27% and boost margins, proving the ROI of a data-driven model.

After years of losses, the electric vehicle maker projects its first-ever adjusted quarterly profit, signaling a new era of financial discipline.